Finance

The Alger Weatherbie Specialized Growth Fund's Class A shares demonstrated underperformance against the Russell 2500 Growth Index during the initial quarter of 2026. This comprehensive analysis will explore the factors influencing the fund's overall performance, examining the individual contributions of various portfolio companies, distinguishing between those that excelled and those that faced challenges. We aim to provide a detailed understanding of the market dynamics and strategic decisions that shaped these outcomes.

Several companies within the fund's portfolio showcased noteworthy performances. AAR Corp. delivered exceptional fiscal third-quarter results, surpassing revenue, earnings, and profitability forecasts, largely propelled by robust organic expansion in its parts supply division. DigitalOcean Holdings, Inc. also presented a strong fiscal fourth-quarter report, exceeding revenue and profitability expectations, with new annual recurring revenue reaching an unprecedented level. Furthermore, Legence Corp. exhibited significant growth, driven predominantly by data center-related ventures, alongside impressive revenue acceleration and earnings growth.

Conversely, some holdings encountered headwinds. Casella Waste Systems, Inc., despite achieving a fifth consecutive year of double-digit revenue and earnings growth, faced investor apprehension due to stagnant volume growth. Planet Fitness, Inc. reported better-than-anticipated fiscal fourth-quarter results, but its full-year guidance indicated a projected slowdown in revenue growth compared to the previous year, raising concerns among investors regarding decelerating growth, evolving consumer preferences, and heightened competition in the affordable fitness sector. These varying performances underscore the complex and dynamic nature of the market, necessitating a nuanced investment approach.

The detailed commentary from the Alger Weatherbie Specialized Growth Fund for Q1 2026 sheds light on these individual company results and their collective impact on the fund's performance. By dissecting both the successes and the areas of underperformance, the fund's management continuously refines its strategy to navigate the intricate landscape of specialized growth investments.

Unlocking Value: Finch's Strategic Pivot Towards Shareholder Optimization

Finch Therapeutics Faces Share Price Adjustments and Legal Victories

Finch Therapeutics experienced a notable reduction in its stock valuation, moving from $13.49 at the close of 2025 to $9.64 by the end of the first fiscal quarter. This shift occurred amidst significant legal developments, including a successful jury trial in August 2024. In this trial, Finch secured a favorable verdict against Ferring Pharmaceuticals, with the jury affirming Ferring's infringement on three of Finch's proprietary patents. This legal triumph underscores the intrinsic value of Finch's intellectual property, despite fluctuations in its market price.

Strategic Chapter 11 Filing to Streamline Operations and Monetize Assets

In a decisive move to optimize its financial structure and unlock inherent value, Finch Therapeutics initiated a strategic Chapter 11 bankruptcy filing. This procedural step was specifically designed to facilitate the elimination of burdensome lease obligations and to orchestrate a comprehensive sale of the company's assets. The aim is to transition from a publicly traded entity to a more streamlined operation that can effectively monetize its holdings. The Arquitos Capital Management firm advocates for this approach, believing it will yield greater returns for shareholders by efficiently converting assets into capital.

Comprehensive Asset Divestiture: Litigation, Patents, and Corporate Structure

The planned asset sale encompasses a broad spectrum of Finch's valuable holdings. This includes the successful litigation claim against Ferring, which represents a significant potential recovery. Furthermore, the sale will feature an extensive portfolio of 160 issued patents, a testament to Finch's innovative capacity. The process also includes addressing another potential infringement case involving a major global corporation. Importantly, the corporate shell itself is part of this divestiture strategy, indicating a complete restructuring aimed at maximizing shareholder returns from all available resources. This holistic approach to asset monetization is central to the company's strategy.

Arquitos Capital's Vision: Maximizing Shareholder Value Through Restructuring

Arquitos Capital Management expresses strong conviction that this strategic restructuring process will ultimately maximize the value for Finch shareholders. Their assessment suggests that the current market environment and the complexities of managing a public company might not fully reflect the true worth of Finch's assets, especially its intellectual property and litigation claims. By moving through a Chapter 11 filing and executing a controlled sale, the company can more effectively monetize these assets. This approach is perceived as a superior method to achieve a healthy premium for its holdings, surpassing what could be realized if Finch were to continue operating as a conventional publicly traded entity. The goal is to ensure that shareholders receive the highest possible benefit from the company's underlying strengths.